MCRB

MKT CAP:$74M

Seres Therapeutics Inc

Market Cap

$74M

Healthcare·Biotechnology·🇺🇸 United States·NASDAQ

Healthcare·Biotechnology·🇺🇸·NASDAQ

Stock Price

$6.63-$8.52 (-56.24%)

Jun 5, 2026

52W High $28.6352W Low $6.63

Company Details

Seres Therapeutics, Inc., a clinical-stage company, focuses on developing biotherapeutics for serious diseases. The company develops SER-155, an investigational oral live biotherapeutic to decolonize GI pathogens, enhance GI epithelial barr...

CEO

—

IPO Date

Jun 26, 2015

Website

www.serestherapeutics.com

Key Metrics TTM

Revenue

$1M

-80.7% YoY

Net Income

-$47M

EPS (Diluted)

Free Cash Flow

-$42M

Revenue / Share

$0.12

Gross Margin

-20.9%

Operating Margin

-7641.0%

Net Margin

-4088.8%

FCF Margin

-3694.1%

P/S

64.5x

P/E

Earnings Reports

Q2 2026

Aug 5, 2026

PENDING

Q1 2026

May 5, 2026

$358.0K

FY 2025

Mar 12, 2026

$789.0K

Q4 2025

Mar 12, 2026

$438.0K-92.6%

Q3 2025

Nov 5, 2025

$351.0K

Revenue & Profitability

Valuation

Operating Cash Flow

CapEx Spend

OpEx vs Revenue Growth (YoY)

Stock-Based Compensation

OpEx Breakdown

War Chest

Shares Outstanding

Revenue Per Employee

Revenue / Employee